How Preoperative Immunotherapy Can Change the MPM Treatment Landscape and Improve Outcomes
source: pixabay.com

How Preoperative Immunotherapy Can Change the MPM Treatment Landscape and Improve Outcomes

Historically, mesothelioma has been difficult to treat. Although treatment options exist, the cancer tends to respond poorly which results in a higher mortality rate. Improving patient care and outcomes (such…

Continue Reading How Preoperative Immunotherapy Can Change the MPM Treatment Landscape and Improve Outcomes
A Biomarker for Niemann-Pick Disease Type C Could Improve Congenital Disorders of Glycosylation Diagnosis
source: pixabay.com

A Biomarker for Niemann-Pick Disease Type C Could Improve Congenital Disorders of Glycosylation Diagnosis

Let’s start with a little vocabulary lesson. Today’s word? Biomarker. A biological marker, or biomarker, refers to some sort of measurable indicator of disease. For example, blood pressure, cellular gene…

Continue Reading A Biomarker for Niemann-Pick Disease Type C Could Improve Congenital Disorders of Glycosylation Diagnosis
NC Family Raises SYNGAP1 Awareness After Daughter’s Diagnosis
https://pixabay.com/en/dna-dns-biology-genetic-material-1388696/

NC Family Raises SYNGAP1 Awareness After Daughter’s Diagnosis

The first few years of Saylor Baysden’s life involved a good deal of medical confusion. Her family pursued testing, leading to two diagnoses in 2020-21: autism and epilepsy. But her…

Continue Reading NC Family Raises SYNGAP1 Awareness After Daughter’s Diagnosis
Rare Classroom: Anal Cancer
source: shutterstock

Rare Classroom: Anal Cancer

Welcome to the Rare Classroom, a new series from Patient Worthy. Rare Classroom is designed for the curious reader who wants to get informed on some of the rarest, most…

Continue Reading Rare Classroom: Anal Cancer
New Guidance from the FDA Intends to Improve Cancer Clinical Trials for Accelerated Approval
source: shutterstock.com

New Guidance from the FDA Intends to Improve Cancer Clinical Trials for Accelerated Approval

According to a press release from the US Food and Drug Administration (FDA), on March 24, 2023, the agency issued a new draft guidance titled Clinical Trial Considerations to Support Accelerated…

Continue Reading New Guidance from the FDA Intends to Improve Cancer Clinical Trials for Accelerated Approval
Enrollment Complete for Phase 3 Study Evaluating Brensocatib for Non-CF Bronchiectasis
source: shutterstock.com

Enrollment Complete for Phase 3 Study Evaluating Brensocatib for Non-CF Bronchiectasis

  People living with bronchiectasis, a chronic condition characterized by damaged airways, experience progressive lung damage and inflammation. This can lead to a multitude of consequences, including a reduction in…

Continue Reading Enrollment Complete for Phase 3 Study Evaluating Brensocatib for Non-CF Bronchiectasis
Rare Community Profiles: Their Daughter’s Rare Disease Empowered the Traller Family to Advocate for ASPS Awareness and Research
source: shutterstock.com

Rare Community Profiles: Their Daughter’s Rare Disease Empowered the Traller Family to Advocate for ASPS Awareness and Research

Rare Community Profiles     Rare Community Profiles is a new Patient Worthy article series of long-form interviews featuring various stakeholders in the rare disease community, such as patients, their…

Continue Reading Rare Community Profiles: Their Daughter’s Rare Disease Empowered the Traller Family to Advocate for ASPS Awareness and Research

Pitolisant Reduced Excessive Daytime Sleepiness in Children with Narcolepsy

  Currently, the standards-of-care for narcolepsy include lifestyle changes involving diet and exercise, behavioral therapy, nap therapy, and certain medications designed to combat excessive daytime sleepiness. However, a majority of…

Continue Reading Pitolisant Reduced Excessive Daytime Sleepiness in Children with Narcolepsy